Court Rolls Up CBD Class Action (At Least For Now)

We keep reading in Law360 and other publications about defense law firms that are ramping up cannabis practice groups. Our own firm is one of them. These developments sparked an interest. After all, won't many of the principles we've worked with over the years for prescription and OTC medications apply to pot and its dressed-up cousins? Or is that just wacky? We'd like to be invited to join a CBD group, even as an adjunct member, but we won't hold our breath. Anyway, plaintiffs are apparently doing something similar, as we start to see lawsuits alleging problems with cannabidiol (CBD) products. (We have written before about whether the learned intermediary rule should apply to cannabis lawsuits.) Such cannabis lawsuits often focus on whether the CBD product is as strong as advertised.